According to a recent study, the amount you pay in taxes may be linked to your risk of developing cancer. Researchers discovered a correlation between higher tax rates and lower cancer mortality rates.
Specifically, for each additional $1,000 in tax revenue collected per person annually, the cancer death rate appears to drop by up to four percent.
States like New York, Connecticut, and New Jersey, which have higher tax rates, reported some of the lowest cancer mortality rates in the nation. In contrast, states with lower income taxes, such as Mississippi, Tennessee, and Kentucky, tended to have much higher mortality rates.
The study suggests that the reason for this might be that states with elevated tax rates are more likely to provide access to cancer screenings and other early detection tests.
It was found that a $1,000 increase in tax revenue was associated with a roughly two percent uptick in cancer screening rates.
The research team, consisting of experts from Ohio State University, Emory University, and the University of Verona in Italy, posited that the better health outcomes observed in higher-tax states could be a direct result of these taxes funding important screening initiatives, such as mobile testing units.
However, there were exceptions. For instance, Utah had the lowest cancer mortality rate among all states while also being one of the states with the lowest tax rates. This lower mortality could be attributed to dietary and lifestyle choices, as well as a reduced prevalence of smoking and alcohol consumption in this predominantly religious state.
In their findings, researchers noted, “Creating tax structures that focus on high revenue and progressive strategies may help address persistent inequities in cancer care in the U.S.”
Published in JAMA Network Open, the study examined data collected from various sources, including the U.S. Census Bureau and the Institute on Taxation and Economic Policy, to analyze state tax revenues and corresponding cancer mortality rates from 1997 to 2021.
The analysis indicated that the cancer mortality rate in 2021 was 174 deaths per 100,000 white Americans, while non-Hispanic Black Americans faced a higher rate of 206 per 100,000. Kentucky, in particular, experienced the highest cancer mortality rate at 205 per 100,000, while Utah’s rate stood at 133 per 100,000.
Over two decades, the national average state tax revenue per person was around $4,432, with New York at the top with $8,400, followed closely by Connecticut and New Jersey. Notably, all three states reported cancer mortality rates well below the national average.
In states with lower tax revenues, such as Alabama, Tennessee, and Mississippi, cancer mortality rates soared. Mississippi had the second-highest cancer mortality rate at 201 per 100,000, while Tennessee and South Carolina reported rates of 193 and 184, respectively.
Interestingly, the study indicated that an increase in tax revenue by $1,000 could reduce overall cancer mortality by an average of two percent, with an even greater three percent reduction noted among white individuals. For cancers with recommended screening, like colon and breast cancer, each additional $1,000 was linked to a four percent decrease in mortality rates.
This suggests that increased tax revenues could enhance state health programs, including supporting mobile testing and transportation to screening sites.
Despite Utah’s low cancer rates and tax revenue, the state’s health outcomes might be influenced by lifestyle factors, as it has the lowest smoking rate in the country and a relatively low percentage of binge drinkers.
The researchers pointed out that these well-structured screening programs highlight how effective government spending can foster better health outcomes. However, they also noted a lack of significant progress for minority populations, indicating that enhanced screening efforts may not be reaching these communities adequately.
While the research identified a correlation between tax rates and cancer outcomes, there are limitations. It underscored an association rather than a direct cause-and-effect relationship.
